Stryker SYK Orthopaedics — Capital Expenditures During Period

Similar metrics at other companies

UTIChange in accrued capital expenditures during the period

$5.68M+477%

BKDCCRCs — Capital expenditures:

$5.12M+47.7%

INVTechnology — Capital Expenditures:

$846K-7.7%

KMTInfrastructure — Capital expenditures:

$6.41M-19.8%

ESABAmericas: — Capital expenditures:

$7.23M+65.0%

HOGLiveWire — Capital expenditures:

$751K-47.5%

FAQ

What is Stryker's orthopaedics — capital expenditures during period?

Stryker (SYK) reported orthopaedics — capital expenditures during period of $41M in Q1 2026.

How has Stryker's orthopaedics — capital expenditures during period changed year-over-year?

Stryker's orthopaedics — capital expenditures during period decreased by 16.3% year-over-year, from $49M to $41M.

What is the long-term trend for Stryker's orthopaedics — capital expenditures during period?

Over 3 years (2022 to 2025), Stryker's orthopaedics — capital expenditures during period has grown at a 19.6% compound annual growth rate (CAGR), from $173M to $296M.

What does orthopaedics — capital expenditures during period mean?

This measures the cash spent by the Orthopaedics segment to acquire, maintain, or upgrade physical assets such as manufacturing equipment and facilities. It reflects the segment's ongoing commitment to maintaining production capacity and technological infrastructure. High capital expenditures are often necessary to support new product launches and manufacturing scale.